| Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Mar 24 | Mar 23 | Mar 22 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 137.07 mm | 137.07 mm | 137.07 mm | 137.07 mm | 137.07 mm | |
| Cash burn (monthly) | 29.26 mm | 15.47 mm | 20.39 mm | 52.78 mm | 7.91 mm | |
| Cash used (since last report) | 81.64 mm | 43.16 mm | 56.89 mm | 147.26 mm | 22.08 mm | |
| Cash remaining | 55.43 mm | 93.91 mm | 80.19 mm | -10.19 mm | 114.99 mm | |
| Runway (months of cash) | 1.9 | 6.1 | 3.9 | -0.2 | 14.5 | |
| 13F holders | Current |
|---|---|
| Total holders | 107 |
| Opened positions | 9 |
| Closed positions | 50 |
| Increased positions | 19 |
| Reduced positions | 36 |
| 13F shares | Current |
|---|---|
| Total value | 28.31 bn |
| Total shares | 241.64 mm |
| Total puts | 241.50 k |
| Total calls | 403.90 k |
| Total put/call ratio | 0.6 |
| Largest owners | Shares | Value |
|---|---|---|
| ABeeC 2.0 | 98.63 mm | $33.65 mm |
| GSK GSK | 39.66 mm | $116.21 mm |
| NewView Capital Partners I | 19.46 mm | $6.81 bn |
| NewView Capital Fund I | 19.46 mm | $0.00 |
| Vanguard | 15.57 mm | $5.42 bn |
| Euclidean Capital | 10.24 mm | $3.59 bn |
| Sapphire Ventures, L.L.C. | 5.29 mm | $1.84 bn |
| BLK BlackRock | 4.88 mm | $1.70 bn |
| Geode Capital Management | 4.25 mm | $1.48 bn |
| Renaissance Technologies | 3.09 mm | $1.07 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Nov 24 | Joseph Anthony Selsavage | Class A Common Stock | Payment of exercise | Dispose F | No | No | 3.15 | 5,279 | 16.63 k | 102,122 |
| 26 Aug 24 | Sandra R MD Hernandez | Class A Common Stock | Grant | Acquire A | No | No | 0.3341 | 149,655 | 50.00 k | 1,203,204 |
| 26 Aug 24 | Sandra R MD Hernandez | Class A Common Stock | Grant | Acquire A | No | No | 0 | 658,485 | 0.00 | 1,053,549 |
